3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycystic Ovary Syndrome
10
Weight Loss
5
Obesity
5
Overweight
3
Menstruation Disturbances
2
Intermittent Fasting
2
Tumor Surgery
1
Sarcopenia
1
Postoperative Complications
1
Obesity, Abdominal
1
Muscle Weakness
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Insulin Resistance
1
Infertility
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Esophagectomy
9
Radiotherapy
8
Endoscopic Mucosal Resection
7
Standard of Care
6
Exercise
6
Enteral Nutrition
6
Endoscopy
6
Magnetic Resonance Spectroscopy
5
Fluorouracil
5
Cisplatin
5
Surveys and Questionnaires
4
camrelizumab
3
Yoga
3
Radiofrequency Ablation
3
Radiation
3
Preoperative Exercise
3
Practice Guidelines as Topic
3
Fluorodeoxyglucose F18
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Biopsy
3
spartalizumab
2
X-Rays
2
Robotic Surgical Procedures
2
Psychosocial Intervention
2
Psychiatric Rehabilitation
2
Proton Therapy
2
Physical Therapy Modalities
2
Palliative Care
2
Paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Esophageal Neoplasms
×
Caloric Restriction
×
Clear all
NCT03676478
2025-12-10
EFECTS
University Hospital, Gasthuisberg
Phase NA
Terminated
239 enrolled